Featured Insights and Perspectives from Darwin

The latest insights, ideas, and perspectives from Darwin, updated weekly. Explore a cross-section of up-to-date content from us and other thought leaders on trends in health care, research, and data.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Our Take Newsletter

FDA approves first treatment targeting muscle loss in spinal muscular atrophy

Read Now

News and Insights

Showing items 1 to3 of 6

Topics
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Results 1

Date
Pfizer, BioNTech nab first FDA authorization of a COVID-19 vaccine
Insight
Our Take Newsletter
December 14, 2020

Pfizer, BioNTech nab first FDA authorization of a COVID-19 vaccine

Learn More
December 14, 2020
Pharma strategy, engagement, and market access
2020’s (other) top stories
Insight
Our Take Newsletter
December 21, 2020

2020’s (other) top stories

Learn More
December 21, 2020
IDN trends, challenges, and leadership
Pharma companies sign spate of deals before year-end
Insight
Our Take Newsletter
January 4, 2021

Pharma companies sign spate of deals before year-end

Learn More
January 4, 2021
Pharma strategy, engagement, and market access
The demise of a proclaimed disrupter: Haven comes to a halt
Insight
Our Take Newsletter
January 11, 2021

The demise of a proclaimed disrupter: Haven comes to a halt

Learn More
January 11, 2021
IDN trends, challenges, and leadership
CMS announces NextGen ACO results — and they are impressive
Insight
Our Take Newsletter
January 18, 2021

CMS announces NextGen ACO results — and they are impressive

Learn More
January 18, 2021
Health policy, CMS initiatives and health economics
UnitedHealthcare launches new virtual primary care service; parent company records $15 billion profit for 2020
Insight
Our Take Newsletter
January 25, 2021

UnitedHealthcare launches new virtual primary care service; parent company records $15 billion profit for 2020

Learn More
January 25, 2021
Digital health and emerging technologies
Leading drugmakers persist in the battle against COVID-19
Insight
Our Take Newsletter
February 1, 2021

Leading drugmakers persist in the battle against COVID-19

Learn More
February 1, 2021
Pharma strategy, engagement, and market access
HCA, insurers report billions in profits for 2020, though some saw decline in Q4
Insight
Our Take Newsletter
February 8, 2021

HCA, insurers report billions in profits for 2020, though some saw decline in Q4

Learn More
February 8, 2021
IDN trends, challenges, and leadership
DOJ asks Supreme Court to uphold the ACA, coalition seeks to expand the health care law
Insight
Our Take Newsletter
February 15, 2021

DOJ asks Supreme Court to uphold the ACA, coalition seeks to expand the health care law

Learn More
February 15, 2021
Health policy, CMS initiatives and health economics
14 health systems come together to create health data startup Truveta
Insight
Our Take Newsletter
February 22, 2021

14 health systems come together to create health data startup Truveta

Learn More
February 22, 2021
Digital health and emerging technologies
J&J’s COVID-19 vaccine gains authorization, other vaccine makers provide updates
Insight
Our Take Newsletter
March 1, 2021

J&J’s COVID-19 vaccine gains authorization, other vaccine makers provide updates

Learn More
March 1, 2021
Pharma strategy, engagement, and market access
Merck to help manufacture J&J’s COVID-19 vaccine, acquire Pandion, withdraw Keytruda indication
Insight
Our Take Newsletter
March 8, 2021

Merck to help manufacture J&J’s COVID-19 vaccine, acquire Pandion, withdraw Keytruda indication

Learn More
March 8, 2021
Pharma strategy, engagement, and market access
Stay Aware. Stay Informed.

Want to stay ahead of health care trends?

Sign up for highly curated, expert weekly strategic insights for health care executives and leaders.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.